載入...
PD-L1 immunohistochemistry assay concordance in urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma
PD-L1 immunohistochemistry is used to guide treatment decisions regarding the use of checkpoint immunotherapy in the management of urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma. With increasing PD-L1 testing options, a need has arisen to assess the analytical compara...
Na minha lista:
| 發表在: | Am J Surg Pathol |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750743/ https://ncbi.nlm.nih.gov/pubmed/29750666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000001084 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|